Detail akcie Fortrea Rg-WI online

Business Summary: Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.
Financial Summary: BRIEF: For the nine months ended 30 September 2025, Fortrea Holdings Inc revenues increased 3% to $2.06B. Net loss before extraordinary items increased from $197.6M to $953.7M. Revenues reflect North America segment increase of 5% to $986.5M, Europe segment increase of 6% to $632.2M. Higher net loss reflects Clinical Service segment loss increase from $106.3M to $859M.